Gastric Abnormalities in Humoral Immune Deficiency Syndromes

References

• Rosen F S, Cooper M D, Wedgwood R JP. The primary immunodeficiencies. N Engl J Med 1984; 311: 235–42
   PubMed Web of Science ®Google Scholar
• Rosen F S, Cooper M D, Wedgwood R JP. The primary immunodeficiencies. N Engl J Med 1984; 311: 300–10
   PubMedGoogle Scholar
• Siegal F P, Pernis B, Kunkel H G. Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol 1971; 1: 482–6
   PubMedGoogle Scholar
• Geha R S, Rosen F S, Merler E. Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia. J Clin Invest 1973; 52: 1726–34
   PubMedGoogle Scholar
• Hermans P E, Diaz-Boxu J A, Stobo J D. Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med 1976; 61: 221–37
   PubMed Web of Science ®Google Scholar
• Rosen F S, Wedgwood R J, Eibl M, et al. Primary immunodeficiency diseases. Report of a World Health Organisation Scientific group. Clin Immunol Immunopathol 1986; 40: 166–96
   PubMedGoogle Scholar
• Siegal F P, Siegal M, Good R AG. Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogamma-globulinaemias. N Engl J Med 1978; 299: 172–8
   PubMedGoogle Scholar
• Waldmann T A, Durm M, Broder S, Blackman M, Blaese R M, Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet 1974; 2: 609–13
   PubMed Web of Science ®Google Scholar
• Reinherz E L, Geha R, Wohl M E, Morimoto C, Rosen F S, Schlossman S F. Immunodeficiency associated with loss of TJ inducer T-cell function. N Engl J Med 1981; 204: 811–6
   Google Scholar
• De Gast G C, Wilkins S R, Webster A DB, Rickinson A, Platts-Mills T AE. Functional immaturity of isolated B cells from patients with hypogammaglobulinaemia. Clin Exp Immunol 1980; 42: 535–44
   PubMedGoogle Scholar
• Whittingham S, Mackay I R. Antibody deficiencies. Clin Immunol Allergy 1981; 1: 465–84
   Google Scholar
• Twomey J J, Jordan P H, Laughter A H, Meuwissen H J, Good R A. The gastric disorder in immunoglobulin deficient patients. Ann Intern Med 1970; 72: 499–504
   PubMedGoogle Scholar
• Doe W F. Immunodeficiency and the gastrointestinal tract. Clin Gastroenterol 1983; 12: 839–53
   PubMedGoogle Scholar
• Ament M E, Ochs H D, Davis S D. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes. A study of 39 patients. Medicine 1973; 52: 227–48
   PubMed Web of Science ®Google Scholar
• Webster A DB. Immunodeficiency and gastrointestinal disease. Clinical immunology of the liver and gastrointestinal tract, D R Triger. Wright and Sons Ltd, Bristol 1985; 127–49
   Google Scholar
• Hughes W S, Cerda J J, Holtzapple P, Brooks F P. Primary hypogammaglobulinemia and malabsorption. Ann Intern Med 1971; 74: 903–10
   PubMed Web of Science ®Google Scholar
• Lamers C BHW, Wagener D JT, Assmann K JM, van Tongeren J HM. Jejunal lymphoma in a patient with primary adult-onset hypogammaglobulinemia and nodular lymphoid hyperplasia of the small intestine. Dig Dis Sci 1980; 25: 553–7
   PubMedGoogle Scholar
• Hughes W S, Brooks F P, Conn H O. Serum gastrin levels in primary hypogammaglobulinemia and pernicious anemia. Ann Intern Med 1972; 77: 746–50
   PubMedGoogle Scholar
• Eriksson S, Clase L, Moquist-Olsson I. Pernicious anemia as a risk factor in gastric cancer. Acta Med Scand 1981; 210: 481–4
   PubMedGoogle Scholar
• Gatti R A, Good R A. Occurrence of malignancy in immunodeficiency diseases. Cancer 1971; 28: 89–98
   PubMed Web of Science ®Google Scholar
• Hermans P E, Huizenga K A. Association of gastric carcinoma with idiopathic late-onset immunoglobulin deficiency. Ann Intern Med 1972; 76: 605–9
   PubMedGoogle Scholar
• Battle W M, Brooks F P. Adenocarcinoma of the stomach with common variable immunodeficiency syndrome. Arch Intern Med 1978; 138: 1682–4
   PubMedGoogle Scholar
• Filipovich A H, Spector B D, Kersey J. Immunodeficiency in humans as a risk factor in the development of malignancy. Prev Med 1980; 9: 252–9
   PubMed Web of Science ®Google Scholar
• Rosen F S, Janeway C A. The gammaglobulins. III. The antibody deficiency syndromes. N Engl J Med 1966; 275: 709–15
   PubMed Web of Science ®Google Scholar
• Ament M E. Immunodeficiency syndromes and the gut. Scand J Gastroenterol 1985; 20: 127–35, Suppl 114
   Web of Science ®Google Scholar
• Lederman H M, Winkelstein J A. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 1985; 64: 145–56
   PubMed Web of Science ®Google Scholar
• Kinlen U, Webster A DB, Bird A G, et al. Prospective study of cancer in patients with hypogammaglobulinemia. Lancet 1985; 1: 263–5
   PubMed Web of Science ®Google Scholar
• Lamers C BHW., Jansen J BJM. Hypogammaglobulinaemia and gastric cancer. Lancet 1985; 1: 1100–1
   PubMedGoogle Scholar
• Nomura A MY, Stemmerman G N, Samloff I M. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980; 93: 537–40
   PubMedGoogle Scholar
• Samloff I M, Varis K, Ihamaki T, Siurala M, Rotter J I. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. Gastroenterology 1982; 83: 204–9
   PubMed Web of Science ®Google Scholar
• Defize J, Meeuwissen S GM. Pepsinogens: an update of biochemical, physiological and clinical aspects. J Pediatr Gastroenterol Nutr 1987; 6: 493–508
   PubMedGoogle Scholar
• Forman D, Newell D G, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302–5
   PubMed Web of Science ®Google Scholar
• Burnstein M, Monge E, Leon Barua R, et al. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol 1991; 13: 154–6
   PubMedGoogle Scholar
• Hansson L E, Engstrand L, Evans D J, et al. Helicobacter pylori seropostivity is a risk factor for gastric adenocarcinoma (GAC). Gastroenterology 1992; 102: A361
   Google Scholar
• Parsonnet J, Vandersteen D, Goates J, Sibley R K, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83: 640–3
   PubMedGoogle Scholar
• Normura K, Stemmermann G N, Chyou P H, Kato I, Perez-Perez G I, Blaser M J. Helicobacter pylori infection and gastric carcinoma among Japanese American in Hawaii. N Engl J Med 1991; 325: 1123–36
   PubMedGoogle Scholar
• Parsonnet J, Friedmann D F, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
   PubMed Web of Science ®Google Scholar
• Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risk. Cancer 1990; 66: 2569–74
   PubMed Web of Science ®Google Scholar
• Forman D, Sitas F, Newell D G, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 607–11
   Google Scholar
• Den Hartog G, Jansen J BMJ., Schaardenburg D J, et al. Plasma gastrin responses to bombesin and antral gastrin concentrations in patients with the intestinal type of gastric cancer. Cancer Res 1988; 48: 2296–8
   PubMedGoogle Scholar
• Jansen J BMJ., Lamers C BHW. Serum gastrin responses to bombesin and food in patients with hypergastrinemia. Dig Dis Sci 1982; 27: 303–7
   PubMedGoogle Scholar
• De Jong A JL, Klamer M, Jansen J BMJ., Lamers C BHW. Effect of atropine and somatostatin on bombesin-stimulated plasma gastrin, cholecystokinin and pancreatic polypeptide in man. Regul Pept 1987; 17: 285–93
   PubMedGoogle Scholar
• Ghatei M L, Jung R T, Stevenson J C, et al. Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab 1982; 54: 980–5
   PubMed Web of Science ®Google Scholar
• Den Hartog G, van der Meer J WM, Jansen J BMJ., van Furth R, Lamers C HBW. Decreased gastric secretion in patients with late-onset hypogammaglobulinaemia. N Engl J Med 1988; 318: 1563–7
   PubMedGoogle Scholar
• Den Hartog G. Plasma gastrin response to bombesin in (pre)-cancerous conditions of the stomach. Ph.D. Thesis, University of Leiden, Leiden 1989; 89–104
   Google Scholar
• Siurala M, Varis K, Wiljasla M. Studies of patients with atrophic gastritis: a 10–15 year follow-up. Scand J Gastroenterol 1966; 1: 40–8
   PubMedGoogle Scholar
• Siurala M, Lehtola M, Ihämaki T. Atrophic gastritis and its sequelae. Scand J Gastroenterol 1974; 9: 441–6
   PubMed Web of Science ®Google Scholar
• Sipponen P, Kekki M, Siurara M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer 1984; 49: 521–30
   PubMed Web of Science ®Google Scholar
• Irvine W J, Cullen D R, Mawhinney H. Natural history of autoimmune achlorhydric gastritis. A 1–15 year follow-up study. Lancet 1974; 2: 482–5
   PubMedGoogle Scholar
• Correa P. A Model for gastric cancer epidemiology. Lancet 1975; 2: 58–60
   PubMed Web of Science ®Google Scholar
• Haenszel W, Correa P. Developments in the epidemiology of stomach cancer over the post decade. Cancer Res 1975; 35: 3452–9
   PubMed Web of Science ®Google Scholar
• Cheli R, Santi L, Ciancamerla G, Canciani G. A clinical and statistical follow-up study of atrophic gastritis. Dig Dis Sci 1973; 18: 1061–6
   Google Scholar